169

Successful Raisings

$120.8M

Capital Raised

56,036

OnMarket Crowd

Discover investment opportunities here


Equity Crowdfunding 13 days left

Road Runner Mobile Tyres Pty Ltd

Road Runner Mobile Tyres Pty Ltd
Disrupting the tyre retailing market as one of Australia’s largest and longest operating end-to-end mobile tyre services

 

Road Runner Mobile Tyres is one of Australia’s largest and longest operating end-to end mobile tyre services providing supply, fit, new tyres, wheel alignment and emergency tyre repairs. Operating in the major metropolitan markets of Sydney, Melbourne and Brisbane, they have successfully developed an operating system and customer focus that creates and maintains long term customer relationships.

 

Traditional tyre services require consumers to set aside much of their day driving to and waiting at the tyre service shop. Road Runner Mobile Tyres reduces the time and hassle of changing tyres for companies and car owners by providing a door to door service. Generating $2 million in revenue per annum and operating in a $5.6 billion market, Road Runner Mobile Tyres is changing the way people change their tyres.

 

Before investing please consider the offer document and the general risk warning.

Equity Crowdfunding Closing today

goPassport Australia Pty Ltd

goPassport Australia Pty Ltd
Digital health passport technology with potential to manage international travel with vaccine announcements by Pfizer and Moderna 

 

COVID-19 has caused a dramatic stop to international travel. QANTAS CEO Alan Joyce confirmed this week that proof that you've been vaccinated for COVID-19 will be compulsory for international air travel onboard his aircraft.

 

goPassport has created a digital health passport that provides an end-to-end COVID-19 compliance system for safe international travel. 

 

Before investing please consider the offer document and the general risk warning.

Min. reached - targeting $2 million

247%

$865,844

Raised

5.8-26%

Equity

562

Investors
Equity Crowdfunding 11 days left

Cannatrek Ltd

Cannatrek Ltd
Medicinal cannabis leader in rapid growth mode, controlling the product lifecycle - "from seed to patient"

 

Register here for a LIVE VIRTUAL TOUR of cannabis growing facility on Tues 8 Dec at 1:00pm (AEDT)

 

Cannatrek Limited is a leading Australian medicinal cannabis company, developing production, manufacturing and digital healthcare distribution assets across Australia and globally.  The Company has a full suite of medicinal cannabis licences, providing complete control of the entire supply-chain and product lifecycle – "from seed to patient".

 

With an operational 3,200m2 growing facility in Queensland, yielding market ready product in commercial quantities, Cannatrek is also rolling out a digital healthcare platform for patients and healthcare professionals to serve the rapidly growing Australian medicinal cannabis market.

 

Before investing please consider the offer document and the general risk warning.

Min. reached - targeting $2.5 million

375%

$1,873,082

Raised

1 - 4%

Equity

516

Investors
IPO Live

Medallion Metals Ltd

Medallion Metals Ltd
Australian gold exploration and development company targeting 80,000 p.a. ounce production

 

Medallion Metals Ltd (ASX: MM8) is a resources exploration and development company looking to build a long life, high margin gold business in Australia with the initial focus on advancing the Ravensthorpe Gold Project located in the Goldfields-Esperance region of Western Australia.

 

With JORC compliant estimates of approximately 674,000 ounces of gold, the Company is focused on advancement of near mine exploration targets and updating the feasibility study completed in May 2020. The intention is to advance to final investment decision, and ultimately production targeting 80,000 ounces per annum. 

 

Medallion also owns the nearby Jerdacuttup Project, which is prospective for base and precious metals, and contains JORC Code compliant Mineral Resources estimates.

$0.40Price
Up to $20 millionSize of Offer
19 Nov 20Offer Open
07 Dec 20Pay By
SPP Harvester Live

SPP Harvester

SPP Harvester
Harvesting the discount from Share Purchase Plans

 

The COVID-19 pandemic has caused a wave of discounted capital raisings with ~$56 billion of discounted new shares issued this year.

 

Share Purchase Plans (SPPs) allow individual shareholders to apply for up to $30,000 in shares at the same discounted price paid by institutions.  In the 6 months to 30 June, in-the-money SPPs were issued at an average 11% discount to the ASX closing price on the SPP closing date. But, you must be a shareholder before the SPP is announced.

 

SPP HarvesterTM gives you access to SPPs by buying you 1-share in 300 of the largest, liquid, operating companies listed on ASX.  It will identify and apply for in-the-money SPPs and automatically sell the new securities, efficiently recycling your capital into the next SPP. This automatically harvests the discount for SPPs, with minimum capital outlay, low establishment costs and minimal administration. 

$1.00Price
UnlimitedSize of Offer
27 Nov 20Offer Open
11 Dec 20Pay By
Dual Listing Live

TruScreen Group Ltd ASX: TRU

TruScreen Group Ltd
Patented cervical cancer detection system, providing an accurate, real-time screening solution

 

The company has advised that they have reached the minimum subscription.

 

TruScreen Group Limited (ASX: TRU) manufactures and owns all rights to the patented TruScreen Cervical Cancer Screening System. The system uses an AI supported process to detect  pre-cancerous and cancerous tissue in real time and is at the forefront of the development of objective opto-electric tissue differentiation. The TruScreen solution aims to  improve the wellbeing of women and is ideal for communities that can’t access conventional laboratory dependant screening methods. 

 

The Company’s has distribution agreements in 23 countries with its products sold to China, Vietnam, Russia, Zimbabwe, Mexico, India, and Saudi Arabia. The Company is planning to establish a manufacturing plant in China as this currently accounts for over 50% of sales.  

$0.065Price
~$1.85m (NZ$2m)Size of Offer
26 Nov 20Offer Open
17 Dec 20Pay By
Convertible Note Live

Fitgenes Australia Ltd

Fitgenes Australia Ltd
DNA based health tech company focused on obesity and cardiometabolic health

 

Fitgenes is an Australian unlisted public DNA based health tech company focused on obesity and cardiometabolic health. Fitgenes has developed a suite of comprehensive customised nutrigenomic data products which it sells and delivers to health practitioners in Australia, New Zea land, parts of Asia and increasingly Europe and USA.  Fitgenes has trained over 1200 practitioners on its Pracware platform, with plans to expand.

 

Established in 2002 with a goal to make optimal healthy living and healthy ageing DNA based information accessible to everyone.

 

This offer is restricted to professional, sophisticated and experienced investors.  More info here.

$1.00Price
Up to $600,000Size of Offer
15 Oct 20Offer Open
17 Dec 20Pay By
Restricted Offer Live

COMtrac (IMA Pty Ltd)

COMtrac (IMA Pty Ltd)
Ground-breaking end-to-end investigation management system heralded by the industry as a game-changer to investigation management

 

COMtrac is a transformational investigation management technology solution business founded by Craig Doran, a former senior investigator with Queensland Police.  COMtrac is a proven solution to a problem widespread among multiple sectors – and provides a streamlined, superior level of rigor, transparency, consistency, and efficiency to the current investigative and evidence management process across law enforcement, insurance, legal firms, government, industrial relations, workplace complaints and incidents, consulting, banking and finance, and accounting institutions.

 

With a rapidly growing AAA customer base globally, COMtrac has already facilitated more than 180,000 investigations since launch with revenue already exceeding $1M this year with the investigation management solution set to transform the landscape and practice of investigation management.   

 

This offer is restricted to professional, sophisticated, and experienced investors.  More info here.

$1.44Price
Up to $1.5 millionSize of Offer
25 Nov 20Offer Open
18 Dec 20Pay By
Equity Crowdfunding Upcoming

Foresense Technologies Ltd

Foresense Technologies Ltd
A disruptive innovator in real-time customer presence analytics

More Info

Foresense Technologies has developed an artificial intelligence solution enabling brick and mortar stores to more effectively compete with the growing presence of ecommerce. Proprietary technology allows retailers to understand and improve the experience and engagement of their customers.

 

Signed agreements with leading outdoor media company, a network of 4,000 newsagents across Australia, as well as final negotiations with a large US based casino group, a major national retailer and several other iconic global brands.

 

Foresense is positioning itself as a global leader in the customer presence and analytics market

 

Before investing please consider the offer document and the general risk warning.

Public Offer OnMarket Bidding Closed

Sprintex Ltd ASX: SIX

Sprintex Ltd
Leading supplier of automotive superchargers, reducing emissions and fuel consumption

 

Payment for applications must be made by 5pm, Friday 4 December (AEST)

 

Sprintex Limited (ASX: SIX) is an Australian based automotive engineering, research, product development and manufacturing company that designs and manufactures superchargers for use in a wide variety of combustion engines. It is currently focused on the development and commercialisation of the Sprintex® twin screw supercharger in the automotive aftermarket and original equipment manufacturer (OEM) market in Australia, USA, Asia, Africa and the Middle East.

 

The patented Sprintex supercharger plays a key role in reducing fuel consumption and lowering emissions in combustion engines, which is assist in meeting increasingly stringent environmental standards.

$0.086Price
$6.5 millionSize of Offer
06 Nov 20Offer Open
04 Dec 20Pay By
IPO Bidding Closed

Payright Ltd ASX: PYR

Payright Ltd
Emerging BNPL provider specialising in higher‑value, more considered purchases

 

Offer closed via OnMarket.  All payments for applications must be made by 5pm Friday 27 November.  

 

Payright Ltd (ASX: PYR) specialises in providing merchants in Australia and New Zealand with both in‑store and online buy now pay later (BNPL) solutions for the benefit of their customers, with a focus towards higher‑value and more considered purchase items as opposed to lower value and more impulse‑driven transactions generally associated with other parts of the BNPL sector.

 

Payright specialises in transactions between $1,000 and $20,000, and offers varied and flexible customer repayment terms of up to 60 months.

 

$1.20Price
Up to $20 millionSize of Offer
18 Nov 20Offer Open
27 Nov 20Pay By
Placement Closed Nov 2020

MedAdvisor Ltd ASX: MDR

MedAdvisor Ltd

The MedAvider Ltd (MDR) placement has successfully completed the institutional component of the accelerated non-renounceable entitlement offer and institutional placement raising approximately AUD $35 million, exceeding the minimum required to complete the acquisition of Adheris Health.

Fully Funded
$35 millionSize of Offer
Peloton Capital Lead Manager

Performance of OnMarket IPOs and Placements

Our performance has motivated members to share OnMarket, earning them over $245,769 in rewards.

The average returns by days post-listing are...

+6.3%
1 day
+5.8%
1 Month
+10.2%
3 months
+19.4%
6 months

*Based on both open and closed positions of the 142 listed offers  as at 1 November 2020.

Performance figures are calculated using a simple average method.

See comprehensive breakdown and calculation of returns

 

OnMarket partners include

 

 

 

 

INVESTOR STORY

OnMarket allows me to invest in companies that I want to see succeed and make an impact on the world, read my investor story

SAM, INVESTOR FROM SCONE, NSW

Risk warning


Crowd-sourced funding is risky. Issuers using this facility include new or rapidly growing ventures. Investment in these types of ventures is speculative and carries high risks. You may lose your entire investment, and you should be in a position to bear this risk without undue hardship. Even if the company is successful, the value of your investment and any return on the investment could be reduced if the company issues more shares. Your investment is unlikely to be liquid. This means you are unlikely to be able to sell your shares quickly or at all if you need the money or decide that this investment is not right for you.
Even though you have remedies for misleading statements in the offer document or misconduct by the company, you may have difficulty recovering your money. There are rules for handling your money. However, if your money is handled inappropriately or the person operating this platform becomes insolvent, you may have difficulty recovering your money. Ask questions, read all information given carefully, and seek independent financial advice before committing yourself to any investment.